Victoza (Liraglutide)

Victoza (liraglutide) is considered an injectable incretin mimetic. It is a relatively new drug used to treat type 2 diabetes. It is commonly mistaken with dulaglutide. Although it holds the same ingredients as Saxenda, they two medications do have their differences.

It is commonly recommended for adults and children over the age of 10 with type 2 diabetes to be used in conjunction with diet and lifestyle modifications to improve glycaemic control.

Incretin mimetics have been proven to be effective in lowering blood glucose. Clinical research studies have also been shown to be beneficial for weight loss compared to subjects on the placebo when used in combination with diet and exercise.